"to save lives and make healthcare delivery more effective"
DNA sequencing using panels could improve outcomes in 16% of patents based on published data. We estimate that OneRNA™ can improve outcome in most patients. That is a very strong statement which we obviously need to prove, hense our clinical programs.
We have started to better understand how we could utilize our data to design next generation cancer vaccines and combinatorial immune therapies.
Genomic Expression presented data on how to get great RNA-seq data from FFPE in collaboration with Beckman Coulter. If you missed it you can access it here.
CEO Genomic Expression